"Biological Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc.
| Descriptor ID |
D001681
|
| MeSH Number(s) |
E05.091
|
| Concept/Terms |
Biological Assay- Biological Assay
- Assay, Biological
- Biological Assays
- Biologic Assays
- Biologic Assay
- Assay, Biologic
- Assays, Biologic
- Bioassay
- Bioassays
- Assays, Biological
|
Below are MeSH descriptors whose meaning is more general than "Biological Assay".
Below are MeSH descriptors whose meaning is more specific than "Biological Assay".
This graph shows the total number of publications written about "Biological Assay" by people in this website by year, and whether "Biological Assay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biological Assay" by people in Profiles.
-
Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis. Cell Rep. 2021 04 13; 35(2):108991.
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12(1):1-222.
-
Quantitation of in vitro a-1 adrenergic receptor antagonist binding capacity to biologic melanin using tandem mass spectrometry. Curr Eye Res. 2013 Dec; 38(12):1214-20.
-
Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol. 2010 Mar; 31(3):262-8.
-
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord. 2008 Jul 30; 23(10):1353-60.
-
Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot Cell. 2007 Aug; 6(8):1486-96.
-
Detection and molecular mass determination of an HIV replication-enhancing female genital tract factor using a blot bioassay. Biotechniques. 2000 Mar; 28(3):478, 480, 482, 484 passim.
-
Quantitative immunoassay of recombinant murine neuroleukin. Neuroscience. 1988 Oct; 27(1):41-8.
-
Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol. 1988 Jan; 23(1):121-8.